+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Medical Interlocking Intramedullary Nails Market by Implant Material, Design Attributes, Fracture Location, Surgical Technique, Patient Category, Distribution Channel, Hospital Profile - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6159466
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Orthopedic trauma management has undergone a profound evolution driven by advances in biomaterials, surgical techniques, and patient-centered care. Interlocking intramedullary nails now serve as the cornerstone for stabilizing long bone fractures, delivering enhanced biomechanical stability, accelerated healing, and reduced complication rates. This executive summary delivers a strategic overview of the market, spotlighting pivotal developments, regulatory influences, and emerging opportunities. It synthesizes the latest innovations in implant materials, optimized geometries, and integrated locking systems, while examining the broader implications of shifting reimbursement models and cross-border trade dynamics. By framing the market through granular segmentation and regional performance metrics, this introduction establishes the foundation for data-driven decision-making. As demand for minimally invasive procedures escalates across adult, geriatric, and pediatric cohorts, stakeholders must remain agile in adapting product portfolios, cultivating trauma center partnerships, and refining go-to-market strategies. Subsequent sections delve into transformative shifts reshaping the competitive terrain, quantify the impact of forthcoming U.S. tariffs, and extract actionable intelligence from both macroeconomic trends and granular segment analyses. This carefully curated narrative empowers executives, product managers, and commercial teams to chart a course toward sustained growth and surgical excellence in the interlocking intramedullary nail market.

Transformative Shifts Shaping the Competitive Terrain

The landscape of interlocking intramedullary nails is transforming under the influence of several converging forces. First, the integration of advanced biomaterials-most notably titanium alloys like Grade 5-has unlocked superior strength-to-weight ratios and corrosion resistance. Concurrently, design innovations such as modular construction and optimized geometry have elevated implant flexibility, enabling tailored fixation for complex fracture patterns. Surgeons are embracing expandable designs and percutaneous approaches to minimize soft tissue disruption and boost recovery timelines.

Digital health platforms are fostering real-time intraoperative guidance, while additive manufacturing techniques are shortening lead times for custom instrumentation. Regulatory agencies are accelerating approvals for next-generation implants, reflecting growing confidence in long-term safety and efficacy data. At the same time, reimbursement frameworks are evolving to reward value-based outcomes, prompting device innovators to demonstrate cost-effectiveness alongside clinical performance. These shifts are collectively recalibrating competitive dynamics: established orthopedic giants are forging strategic partnerships with technology startups, while nimble newcomers leverage niche expertise to challenge incumbents. As stakeholder expectations rise, the market is primed for a new era in fracture stabilization-one defined by precision, personalization, and performance.

Evaluating the 2025 U.S. Tariff Implications

The imposition of new U.S. tariffs scheduled for 2025 will exert multifaceted pressure on the interlocking intramedullary nail market. By elevating duties on imported orthopedic hardware and raw materials-particularly high-grade alloys-the policy is set to inflate production costs for manufacturers reliant on global supply chains. This cost uptick will reverberate through pricing strategies, potentially triggering margin compression or list price increases. In response, several market leaders are contemplating localized manufacturing expansions, onshoring key production processes to mitigate duty impacts and benefit from domestic incentives.

Beyond direct cost implications, the tariffs may prompt a reevaluation of sourcing strategies, driving companies to diversify supplier portfolios across low-tariff jurisdictions or to vertically integrate material processing. However, accelerated localization introduces capital expenditure demands and logistical complexities. Payers and providers may push back on price inflation, intensifying negotiations around value-based contracting and bundled payment models for fracture care. Firms that proactively adjust their commercial models-aligning with evolving reimbursement paradigms and securing long-term supply agreements-will be best positioned to preserve profitability while meeting surgeon and patient expectations.

Key Segmentation Insights Driving Market Dynamics

A detailed segmentation analysis reveals nuanced demand drivers across multiple dimensions. Implant material preferences show titanium alloys commanding a premium share due to their biocompatibility and fatigue resistance, with Grade 5 variants particularly favored for load-bearing long bone repairs; stainless steel and emerging composite alternatives maintain footholds in cost-sensitive settings. In terms of design, integrated locking mechanisms and optimized geometry are winning over surgeons seeking streamlined instrumentation and reduced intraoperative time, while modular construction platforms cater to complex fracture patterns, and expandable designs enable minimally invasive insertion.

Fracture location significantly influences device selection: femoral interventions-spanning diaphyseal, distal, and proximal regions-constitute the lion’s share of procedures, followed by humeral and tibial applications where anatomical constraints demand custom fixation strategies. Surgical technique segmentation highlights the ascendancy of minimally invasive procedures and percutaneous approaches, which reduce hospital stays and facilitate outpatient care, although open procedures remain indispensable for multifragmentary or comminuted fractures.

Patient category analysis underscores divergent needs: adult and geriatric cohorts drive overall volume through a high incidence of trauma and osteoporotic fractures, while pediatric applications require smaller, growth-accommodating designs. Distribution channel dynamics reveal that hospital procurement continues to dominate, yet ambulatory surgery centers and direct-sales models are gaining traction by offering competitive pricing and streamlined purchasing experiences. Finally, hospital profile insights show that Level I trauma centers and specialized orthopedic facilities adopt cutting-edge implants early, whereas general hospitals and outpatient surgical centers prioritize cost-effective, standardized offerings.

Key Regional Insights and Performance Trends

Regional performance underscores distinct trajectories. In the Americas, robust healthcare infrastructure and high trauma incidence fuel sustained demand, with the United States leading through its advanced orthopedic ecosystem and growing outpatient surgery trends. Latin America presents an emerging opportunity as governments expand private-public partnerships to modernize trauma care, although reimbursement variability and import costs can temper growth.

Europe, the Middle East & Africa exhibits heterogeneous adoption patterns: Western European markets emphasize procedural efficiency and premium implant utilization under well-established reimbursement regimes, while CEE and select GCC nations pursue capacity expansion, often facilitated by international aid and infrastructural investments. South Africa and parts of North Africa are channeling resources into trauma center upgrades, creating niches for cost-effective fixation solutions.

Asia-Pacific stands out for its rapid urbanization and expanding middle-class healthcare spending. Japan and Australia maintain high per-capita surgery rates and early adoption of minimally invasive technologies. Meanwhile, China and India are scaling domestic manufacturing capabilities, aiming to reduce import reliance and offer competitively priced nails. Southeast Asian markets showcase rising demand in both public and private sectors, driven by injury prevalence and evolving surgical expertise.

Insights into Key Market Players and Strategic Postures

A competitive landscape populated by multinational conglomerates, niche specialists, and innovative disruptors shapes the interlocking intramedullary nail market. Industry titan Stryker Corporation leverages its broad surgical portfolio and global distribution prowess to reinforce market share, while Johnson & Johnson’s DePuy Synthes unit drives product differentiation through proprietary materials and integrated digital platforms. Smith & Nephew and Zimmer Biomet Holdings emphasize procedure-based solutions, coupling implant portfolios with soft tissue management systems.

Mid-tier players like B. Braun Melsungen AG and Medtronic plc emphasize geographic expansion and strategic alliances to bolster their trauma franchises, whereas specialists such as Globus Medical and BioMed Implants, Inc. invest heavily in additive manufacturing and bespoke instrumentation. Acumed, LLC and OrthoAdvance Innovations LLC excel in niche segments by introducing modular and expandable designs that cater to critical fracture patterns. Direct sales leaders-including ConMed Corporation, Exactech, and RTI Surgical-capitalize on surgeon relationships to drive adoption in ambulatory settings.

Emerging competitors such as MedNail Systems Inc. and OrthoTech Solutions, Inc. are carving out market share through agile development cycles and targeted clinical collaborations. DJO Global, Inc. and Integra LifeSciences Corporation focus on synergistic portfolios that combine orthobiologics with fixation devices. As M&A activity intensifies, companies that integrate complementary technologies and secure robust manufacturing footprints will command strategic advantage.

Actionable Recommendations for Industry Leaders

Industry leaders should accelerate the integration of advanced titanium alloys-particularly Grade 5 formulations-into their core product lines to meet surgeon preferences for durability and biocompatibility. Simultaneously, expanding minimally invasive instrumentation and percutaneous approach training programs for orthopedic teams will position companies as clinical partners rather than mere suppliers. To counter tariff-driven cost pressures, diversifying supply chains across low-duty jurisdictions and selectively onshoring critical manufacturing steps can safeguard margins.

Moreover, forging strategic alliances with leading Level I trauma centers and specialized orthopedic facilities can generate early clinical data to support premium pricing and reimbursement negotiations. Embracing digital health platforms for intraoperative navigation and postoperative monitoring will differentiate offerings in value-based care environments. Companies should also tailor distribution strategies to capitalize on the rise of ambulatory surgery centers, deploying direct-sales teams equipped to navigate streamlined procurement pathways.

Finally, prioritizing patient-centric design refinements-such as modular geometries that accommodate anatomical variability across adult, geriatric, and pediatric populations-will foster broader clinical adoption. By aligning R&D investments, commercial models, and partnership strategies with these imperatives, organizations can secure sustainable growth amid evolving market dynamics.

Conclusion: Charting the Path Forward

The interlocking intramedullary nail market stands at an inflection point where material science breakthroughs, design ingenuity, and evolving care delivery models converge to create substantial value. Stakeholders who harness these trends-while deftly navigating regulatory shifts and trade headwinds-will unlock competitive advantage. A cognizant approach to segmentation, regional nuances, and the competitive landscape will enable targeted product development and optimized go-to-market execution. As the sector embraces value-based frameworks and outpatient care migration, the ability to demonstrate clinical efficacy, cost-effectiveness, and seamless integration with digital ecosystems will determine long-term success. Ultimately, the organizations that pioneer collaborative relationships with surgical teams and healthcare institutions will drive both improved patient outcomes and robust commercial performance.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Implant Material
    • Composite Material
    • Stainless Steel
    • Titanium Alloy
      • Grade 5
  • Design Attributes
    • Expandable Design
    • Integrated Locking Mechanism
    • Modular Construction
    • Optimized Geometry
  • Fracture Location
    • Femoral Fractures
      • Diaphyseal
      • Distal
      • Proximal
    • Humeral Fractures
    • Tibial Fractures
  • Surgical Technique
    • Minimally Invasive Procedure
    • Open Procedure
    • Percutaneous Approach
  • Patient Category
    • Adult Patients
    • Geriatric Patients
    • Pediatric Patients
  • Distribution Channel
    • Ambulatory Surgery Centers
    • Direct Sales
    • Hospital Procurement
    • Private Clinics
  • Hospital Profile
    • General Hospitals
    • Level I Trauma Centers
    • Outpatient Surgical Centers
    • Specialized Orthopedic Centers
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Acumed, LLC
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • BioMed Implants, Inc.
  • ConMed Corporation
  • DePuy Synthes (Johnson & Johnson)
  • DJO Global, Inc.
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Integra LifeSciences Corporation
  • Medartis AG
  • MedNail Systems Inc.
  • Medtronic plc
  • MicroPort Orthopedics Inc.
  • NovaOrtho Ltd.
  • NuVasive, Inc.
  • OrthoAdvance Innovations LLC.
  • Orthofix Medical Inc.
  • Orthopedic Innovations Inc.
  • OrthoTech Solutions, Inc.
  • OsteoMed L.P.
  • ProOrtho Devices, LLC.
  • RTI Surgical
  • Smith & Nephew plc
  • Stryker Corporation
  • Summit Medical LLC
  • SurgiFix Medical Inc.
  • Tornier Inc.
  • Wright Medical Group N.V.
  • Zimmer Biomet Holdings, Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Medical Interlocking Intramedullary Nails Market, by Implant Material
8.1. Introduction
8.2. Composite Material
8.3. Stainless Steel
8.4. Titanium Alloy
8.4.1. Grade 5
9. Medical Interlocking Intramedullary Nails Market, by Design Attributes
9.1. Introduction
9.2. Expandable Design
9.3. Integrated Locking Mechanism
9.4. Modular Construction
9.5. Optimized Geometry
10. Medical Interlocking Intramedullary Nails Market, by Fracture Location
10.1. Introduction
10.2. Femoral Fractures
10.2.1. Diaphyseal
10.2.2. Distal
10.2.3. Proximal
10.3. Humeral Fractures
10.4. Tibial Fractures
11. Medical Interlocking Intramedullary Nails Market, by Surgical Technique
11.1. Introduction
11.2. Minimally Invasive Procedure
11.3. Open Procedure
11.4. Percutaneous Approach
12. Medical Interlocking Intramedullary Nails Market, by Patient Category
12.1. Introduction
12.2. Adult Patients
12.3. Geriatric Patients
12.4. Pediatric Patients
13. Medical Interlocking Intramedullary Nails Market, by Distribution Channel
13.1. Introduction
13.2. Ambulatory Surgery Centers
13.3. Direct Sales
13.4. Hospital Procurement
13.5. Private Clinics
14. Medical Interlocking Intramedullary Nails Market, by Hospital Profile
14.1. Introduction
14.2. General Hospitals
14.3. Level I Trauma Centers
14.4. Outpatient Surgical Centers
14.5. Specialized Orthopedic Centers
15. Americas Medical Interlocking Intramedullary Nails Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Medical Interlocking Intramedullary Nails Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Medical Interlocking Intramedullary Nails Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Acumed, LLC
18.3.2. Arthrex, Inc.
18.3.3. B. Braun Melsungen AG
18.3.4. BioMed Implants, Inc.
18.3.5. ConMed Corporation
18.3.6. DePuy Synthes (Johnson & Johnson)
18.3.7. DJO Global, Inc.
18.3.8. Exactech, Inc.
18.3.9. Globus Medical, Inc.
18.3.10. Integra LifeSciences Corporation
18.3.11. Medartis AG
18.3.12. MedNail Systems Inc.
18.3.13. Medtronic plc
18.3.14. MicroPort Orthopedics Inc.
18.3.15. NovaOrtho Ltd.
18.3.16. NuVasive, Inc.
18.3.17. OrthoAdvance Innovations LLC.
18.3.18. Orthofix Medical Inc.
18.3.19. Orthopedic Innovations Inc.
18.3.20. OrthoTech Solutions, Inc.
18.3.21. OsteoMed L.P.
18.3.22. ProOrtho Devices, LLC.
18.3.23. RTI Surgical
18.3.24. Smith & Nephew plc
18.3.25. Stryker Corporation
18.3.26. Summit Medical LLC
18.3.27. SurgiFix Medical Inc.
18.3.28. Tornier Inc.
18.3.29. Wright Medical Group N.V.
18.3.30. Zimmer Biomet Holdings, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET MULTI-CURRENCY
FIGURE 2. MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET MULTI-LANGUAGE
FIGURE 3. MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2024 VS 2030 (%)
FIGURE 16. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 18. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2024 VS 2030 (%)
FIGURE 20. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY COMPOSITE MATERIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY GRADE 5, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY EXPANDABLE DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY INTEGRATED LOCKING MECHANISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY MODULAR CONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY OPTIMIZED GEOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DIAPHYSEAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PROXIMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HUMERAL FRACTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TIBIAL FRACTURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY OPEN PROCEDURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PERCUTANEOUS APPROACH, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY GERIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROCUREMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY LEVEL I TRAUMA CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY OUTPATIENT SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SPECIALIZED ORTHOPEDIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 71. CANADA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 72. CANADA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 73. CANADA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 74. CANADA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 75. CANADA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 76. CANADA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 77. CANADA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 78. CANADA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. CANADA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 81. MEXICO MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 82. MEXICO MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 83. MEXICO MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 84. MEXICO MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 85. MEXICO MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 86. MEXICO MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 87. MEXICO MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 88. MEXICO MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 102. ASIA-PACIFIC MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 104. ASIA-PACIFIC MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 106. ASIA-PACIFIC MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 108. ASIA-PACIFIC MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. AUSTRALIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 110. AUSTRALIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 111. AUSTRALIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 112. AUSTRALIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 113. AUSTRALIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 114. AUSTRALIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 115. AUSTRALIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 116. AUSTRALIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. AUSTRALIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 118. CHINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 119. CHINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 120. CHINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 121. CHINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 122. CHINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 123. CHINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 124. CHINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 125. CHINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. CHINA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 127. INDIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 128. INDIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 129. INDIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 130. INDIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 131. INDIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 132. INDIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 133. INDIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 134. INDIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. INDIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 136. INDONESIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 137. INDONESIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 138. INDONESIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 139. INDONESIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 140. INDONESIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 141. INDONESIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 142. INDONESIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 143. INDONESIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. INDONESIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 145. JAPAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 146. JAPAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 147. JAPAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 148. JAPAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 149. JAPAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 150. JAPAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 151. JAPAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 152. JAPAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. JAPAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 154. MALAYSIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 155. MALAYSIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 156. MALAYSIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 157. MALAYSIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 158. MALAYSIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 159. MALAYSIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 160. MALAYSIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 161. MALAYSIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. MALAYSIA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 163. PHILIPPINES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 164. PHILIPPINES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 165. PHILIPPINES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 166. PHILIPPINES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 167. PHILIPPINES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 168. PHILIPPINES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 169. PHILIPPINES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 170. PHILIPPINES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. PHILIPPINES MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 172. SINGAPORE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 173. SINGAPORE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 174. SINGAPORE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 175. SINGAPORE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 176. SINGAPORE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 177. SINGAPORE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 178. SINGAPORE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 179. SINGAPORE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. SINGAPORE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 181. SOUTH KOREA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 182. SOUTH KOREA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 183. SOUTH KOREA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 184. SOUTH KOREA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 185. SOUTH KOREA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 186. SOUTH KOREA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 187. SOUTH KOREA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 188. SOUTH KOREA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. SOUTH KOREA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 190. TAIWAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 191. TAIWAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 192. TAIWAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 193. TAIWAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 194. TAIWAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 195. TAIWAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 196. TAIWAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 197. TAIWAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. TAIWAN MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 199. THAILAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 200. THAILAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 201. THAILAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 202. THAILAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 203. THAILAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 204. THAILAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 205. THAILAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 206. THAILAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. THAILAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 208. VIETNAM MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 209. VIETNAM MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 210. VIETNAM MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 211. VIETNAM MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 212. VIETNAM MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 213. VIETNAM MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 214. VIETNAM MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 215. VIETNAM MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. VIETNAM MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 227. DENMARK MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 228. DENMARK MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 229. DENMARK MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 230. DENMARK MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 231. DENMARK MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 232. DENMARK MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 233. DENMARK MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 234. DENMARK MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. DENMARK MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 236. EGYPT MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 237. EGYPT MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 238. EGYPT MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 239. EGYPT MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 240. EGYPT MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 241. EGYPT MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 242. EGYPT MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 243. EGYPT MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. EGYPT MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 245. FINLAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 246. FINLAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 247. FINLAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 248. FINLAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 249. FINLAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 250. FINLAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 251. FINLAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 252. FINLAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. FINLAND MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 254. FRANCE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 255. FRANCE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 256. FRANCE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 257. FRANCE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 258. FRANCE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 259. FRANCE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 260. FRANCE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 261. FRANCE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. FRANCE MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY HOSPITAL PROFILE, 2018-2030 (USD MILLION)
TABLE 263. GERMANY MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY IMPLANT MATERIAL, 2018-2030 (USD MILLION)
TABLE 264. GERMANY MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY TITANIUM ALLOY, 2018-2030 (USD MILLION)
TABLE 265. GERMANY MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DESIGN ATTRIBUTES, 2018-2030 (USD MILLION)
TABLE 266. GERMANY MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FRACTURE LOCATION, 2018-2030 (USD MILLION)
TABLE 267. GERMANY MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY FEMORAL FRACTURES, 2018-2030 (USD MILLION)
TABLE 268. GERMANY MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY SURGICAL TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 269. GERMANY MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY PATIENT CATEGORY, 2018-2030 (USD MILLION)
TABLE 270. GERMANY MEDICAL INTERLOCKING INTRAMEDULLARY NAILS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. GERMANY MEDICAL INTERLOCKING INTRAMED

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Medical Interlocking Intramedullary Nails market report include:
  • Acumed, LLC
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • BioMed Implants, Inc.
  • ConMed Corporation
  • DePuy Synthes (Johnson & Johnson)
  • DJO Global, Inc.
  • Exactech, Inc.
  • Globus Medical, Inc.
  • Integra LifeSciences Corporation
  • Medartis AG
  • MedNail Systems Inc.
  • Medtronic plc
  • MicroPort Orthopedics Inc.
  • NovaOrtho Ltd.
  • NuVasive, Inc.
  • OrthoAdvance Innovations LLC.
  • Orthofix Medical Inc.
  • Orthopedic Innovations Inc.
  • OrthoTech Solutions, Inc.
  • OsteoMed L.P.
  • ProOrtho Devices, LLC.
  • RTI Surgical
  • Smith & Nephew plc
  • Stryker Corporation
  • Summit Medical LLC
  • SurgiFix Medical Inc.
  • Tornier Inc.
  • Wright Medical Group N.V.
  • Zimmer Biomet Holdings, Inc.